bibliographic resource 3234987 [br/3234987]
https://w3id.org/oc/corpus/br/3234987

is a
title
  • Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours
publication date
  • 2003-01-01
contributor
format
identifier
part of